Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
F1000Research|October 18, 2014
New forms of checks and balances are needed to improve research integrityElizabeth Iorns, Christin ChongCell Cycle (Georgetown, Tex.)|July 8, 2008
Dissecting resistance to endocrine therapy in breast cancerChristopher J Lord, Elizabeth Iorns, Alan AshworthThe Biochemical Journal|November 4, 2008
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitizationElizabeth Iorns, Christopher J Lord, Alan AshworthNature Reviews. Drug Discovery|June 30, 2007
Utilizing RNA interference to enhance cancer drug discoveryElizabeth Iorns, Christopher J Lord, Nicholas Turner, et al.Breast Cancer Research and Treatment|September 28, 2011
Simultaneous analysis of tumor and stromal gene expression profiles from xenograft modelsElizabeth Iorns, Jennifer Clarke, Toby Ward, et al.Carcinogenesis|August 5, 2009
CRK7 modifies the MAPK pathway and influences the response to endocrine therapyElizabeth Iorns, Sanne R Martens-de Kemp, Christopher J Lord, et al.Peerj|September 25, 2015
Registered report: the androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in manDenise Chronscinski, Srujana Cherukeri, Fraser Tan, et al.Plos One|December 18, 2014
Replication attempt: "Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival"Elizabeth Iorns, William Gunn, Jessey Erath, et al.Elife|December 7, 2021
Challenges for assessing replicability in preclinical cancer biologyTimothy M Errington, Alexandria Denis, Nicole Perfito, et al.Journal of the National Cancer Institute|July 3, 2010
The role of SATB1 in breast cancer pathogenesisElizabeth Iorns, H James Hnatyszyn, Pearl Seo, et al.Pageof 3